Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Jordan

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Cytokine|December 18, 2022
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infectionLeon Cords, Robin Woost, Silke Kummer, et al.
The American Journal of Tropical Medicine and Hygiene|February 10, 2026
Fatal Dengue Fever in a Traveler Returning from Togo to GermanyMatin Kohsar, Markus Haar, Jonas Schmidt-Chanasit, et al.
Microbiology Spectrum|December 8, 2022
Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort StudyMarcel S Woo, Thomas Theo Brehm, Marlene Fischer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 26, 2018
Retrospective clinical case series study in 2017 identifies <i>Plasmodium knowlesi</i> as most frequent <i>Plasmodium</i> species in returning travellers from Thailand to GermanyGuenter Froeschl, Hans Dieter Nothdurft, Frank von Sonnenburg, et al.
Plos One|May 6, 2020
Treatment and re-treatment results of HCV patients in the DAA eraFelix Piecha, Jan-Michael Gänßler, Ann-Kathrin Ozga, et al.
BMC Gastroenterology|June 3, 2014
Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infectionMalte H Wehmeyer, Friederike Eißing, Sabine Jordan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 1, 2022
Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022Dominik Nörz, Susanne Pfefferle, Thomas T Brehm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
Journal of Travel Medicine|July 6, 2024
Establishment of a national travel medicine vaccination network to assess reactogenicity of new and rarely used vaccines: a TropNet studyClara Köpke, Camilla Rothe, Andreas Zeder, et al.
Infection|June 5, 2023
Tecovirimat for the treatment of severe Mpox in GermanyLennart Hermanussen, Thomas Theo Brehm, Timo Wolf, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Cytokine|December 18, 2022
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infectionLeon Cords, Robin Woost, Silke Kummer, et al.
The American Journal of Tropical Medicine and Hygiene|February 10, 2026
Fatal Dengue Fever in a Traveler Returning from Togo to GermanyMatin Kohsar, Markus Haar, Jonas Schmidt-Chanasit, et al.
Microbiology Spectrum|December 8, 2022
Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort StudyMarcel S Woo, Thomas Theo Brehm, Marlene Fischer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 26, 2018
Retrospective clinical case series study in 2017 identifies <i>Plasmodium knowlesi</i> as most frequent <i>Plasmodium</i> species in returning travellers from Thailand to GermanyGuenter Froeschl, Hans Dieter Nothdurft, Frank von Sonnenburg, et al.
Plos One|May 6, 2020
Treatment and re-treatment results of HCV patients in the DAA eraFelix Piecha, Jan-Michael Gänßler, Ann-Kathrin Ozga, et al.
BMC Gastroenterology|June 3, 2014
Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infectionMalte H Wehmeyer, Friederike Eißing, Sabine Jordan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 1, 2022
Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022Dominik Nörz, Susanne Pfefferle, Thomas T Brehm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
Journal of Travel Medicine|July 6, 2024
Establishment of a national travel medicine vaccination network to assess reactogenicity of new and rarely used vaccines: a TropNet studyClara Köpke, Camilla Rothe, Andreas Zeder, et al.
Infection|June 5, 2023
Tecovirimat for the treatment of severe Mpox in GermanyLennart Hermanussen, Thomas Theo Brehm, Timo Wolf, et al.
Pageof 6